CA2434970A1 - 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias - Google Patents

3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias Download PDF

Info

Publication number
CA2434970A1
CA2434970A1 CA002434970A CA2434970A CA2434970A1 CA 2434970 A1 CA2434970 A1 CA 2434970A1 CA 002434970 A CA002434970 A CA 002434970A CA 2434970 A CA2434970 A CA 2434970A CA 2434970 A1 CA2434970 A1 CA 2434970A1
Authority
CA
Canada
Prior art keywords
formula
compound
alkyl
aryl
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002434970A
Other languages
English (en)
French (fr)
Inventor
Magnus Bjorsne
Fritiof Ponten
Gert Strandlund
Peder Svensson
Michael Wilstermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2434970A1 publication Critical patent/CA2434970A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002434970A 2001-02-02 2002-01-29 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias Abandoned CA2434970A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0100326-8 2001-02-02
SE0100326A SE0100326D0 (sv) 2001-02-02 2001-02-02 New compounds
PCT/SE2002/000152 WO2002060902A1 (en) 2001-02-02 2002-01-29 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias

Publications (1)

Publication Number Publication Date
CA2434970A1 true CA2434970A1 (en) 2002-08-08

Family

ID=20282824

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002434970A Abandoned CA2434970A1 (en) 2001-02-02 2002-01-29 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias

Country Status (30)

Country Link
US (1) US7144914B2 (enCached4)
EP (1) EP1360187B1 (enCached4)
JP (1) JP2004522749A (enCached4)
KR (1) KR20030074764A (enCached4)
CN (2) CN1854138A (enCached4)
AR (1) AR035423A1 (enCached4)
AT (1) ATE298339T1 (enCached4)
BG (1) BG108035A (enCached4)
BR (1) BR0206791A (enCached4)
CA (1) CA2434970A1 (enCached4)
CZ (1) CZ20032061A3 (enCached4)
DE (1) DE60204755T2 (enCached4)
EE (1) EE200300364A (enCached4)
ES (1) ES2243706T3 (enCached4)
HK (1) HK1063629A1 (enCached4)
HU (1) HUP0302538A3 (enCached4)
IL (1) IL156734A0 (enCached4)
IS (1) IS6874A (enCached4)
MX (1) MXPA03006579A (enCached4)
MY (1) MY136788A (enCached4)
NO (1) NO20033434L (enCached4)
NZ (1) NZ526992A (enCached4)
PL (1) PL363454A1 (enCached4)
PT (1) PT1360187E (enCached4)
RU (1) RU2293085C2 (enCached4)
SE (1) SE0100326D0 (enCached4)
SK (1) SK9702003A3 (enCached4)
UA (1) UA75382C2 (enCached4)
WO (1) WO2002060902A1 (enCached4)
ZA (1) ZA200305345B (enCached4)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0207952A (pt) * 2001-03-07 2004-07-27 Pfizer Prod Inc Moduladores da atividade de receptores de quimiocina
PT1761542E (pt) * 2004-06-09 2008-03-26 Hoffmann La Roche Derivados de octa-hidro-pirrolo[3,4-c) pirrole e o seu uso com agentes antivirais
US7665658B2 (en) 2005-06-07 2010-02-23 First Data Corporation Dynamic aggregation of payment transactions
GB0514018D0 (en) * 2005-07-07 2005-08-17 Ionix Pharmaceuticals Ltd Chemical compounds
KR101859400B1 (ko) 2009-10-23 2018-05-18 얀센 파마슈티카 엔.브이. 오렉신 수용체 조절제로서의 이치환된 옥타하이드로피롤로[3,4-c]피롤
CN102718695B (zh) * 2012-06-25 2014-04-02 华东师范大学 一种氮杂双环[3.3.0]辛烷衍生物的合成方法
AP2015008721A0 (en) 2013-03-15 2015-09-30 Global Blood Therapeutics Inc Compounds and uses thereof for the modulation of hemoglobin
JP6647592B2 (ja) * 2013-07-03 2020-02-14 ルンドベック ラ ホーヤ リサーチ センター,インク. ピロロピロールカルバメート、および関連する有機化合物、医薬組成物、ならびにその医学的使用
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
LT3426251T (lt) 2016-03-10 2022-06-27 Janssen Pharmaceutica Nv Depresijos gydymo būdai, panaudojant oreksino-2 receptoriaus antagonistus
KR20190015492A (ko) 2016-06-08 2019-02-13 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 화학적 화합물
MX2018014032A (es) 2017-03-20 2019-08-21 Forma Therapeutics Inc Composiciones de pirrolopirrol como activadores de piruvato cinasa (pkr).
CN113226356A (zh) 2018-09-19 2021-08-06 福马治疗股份有限公司 活化丙酮酸激酶r
EP3853206B1 (en) 2018-09-19 2024-04-10 Novo Nordisk Health Care AG Treating sickle cell disease with a pyruvate kinase r activating compound
RU2726120C1 (ru) * 2019-09-24 2020-07-09 Федеральное государственное бюджетное научное учреждение Уфимский федеральный исследовательский центр Российской академии наук N-алкил-n-{ [3-алкил-3,8-диазабицикло[3.2.1]окта-1(7),5-диен-8-ил]метил} амины, обладающие цитотоксической активностью в отношении клеточной линии нек 293

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2428792A1 (de) * 1974-06-14 1976-01-02 Knoll Ag Neue antiarrhythmika
DE3112055A1 (de) * 1981-03-27 1982-10-07 Basf Ag, 6700 Ludwigshafen Bispidinderivate, ihre herstellung und diese enthaltende arzneimittel
DE3234697A1 (de) * 1982-09-18 1984-03-22 Kali-Chemie Pharma Gmbh, 3000 Hannover Neue diazabicyclo-(3,3,1)-nonane
PT88381B (pt) 1987-09-09 1995-07-06 Kali Chemie Pharma Gmbh Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos
DE3732094A1 (de) 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
DE3930266A1 (de) * 1989-09-11 1991-03-14 Thomae Gmbh Dr K Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US5110933A (en) 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
US5468858A (en) * 1993-10-28 1995-11-21 The Board Of Regents Of Oklahoma State University Physical Sciences N-alkyl and n-acyl derivatives of 3,7-diazabicyclo-[3.3.1]nonanes and selected salts thereof as multi-class antiarrhythmic agents
DE4338396A1 (de) 1993-11-10 1995-05-11 Basf Ag N-Substituierte Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
DE4341403A1 (de) 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
DE4402931A1 (de) 1994-02-01 1995-08-03 Kali Chemie Pharma Gmbh Neue 3-Phenylsulfonyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel
US5457121A (en) * 1994-09-02 1995-10-10 Eli Lilly And Company Cis-hexahydro-5-(1,2,3,4-tetrahydro-2-naphthalenyl)pyrrolo<3,4-c>pyrroles as inhibitors of serotonin reuptake
DK0728758T3 (da) * 1995-02-27 2004-02-23 Hoffmann La Roche Dioxopyrrolo-pyrrolderivater
CA2218088A1 (en) * 1995-05-11 1996-11-14 Pharmacia & Upjohn Company Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones
JPH11510478A (ja) * 1995-06-06 1999-09-14 アボツト・ラボラトリーズ キノリジノン型化合物
JPH11512429A (ja) 1995-09-15 1999-10-26 ファルマシア・アンド・アップジョン・カンパニー アミノアリールオキサゾリジノン n−オキシド
GB9519563D0 (en) * 1995-09-26 1995-11-29 Merck Sharp & Dohme Therapeutic agents
DE69717287T2 (de) 1996-08-13 2003-09-11 Merck & Co Inc Palladiumkatalysierte indolisierung
US5808064A (en) * 1996-08-13 1998-09-15 Merck & Co., Inc. Palladium catalyzed indolization
SE9704709D0 (sv) 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
US6355641B1 (en) * 1999-03-17 2002-03-12 Syntex (U.S.A.) Llc Oxazolone derivatives and uses thereof
DE19932621A1 (de) * 1999-07-13 2001-04-26 Bayer Ag Neue substituerte alpha, beta-anellierte Butyrolactone
MY145722A (en) * 2000-04-27 2012-03-30 Abbott Lab Diazabicyclic central nervous system active agents
EP1339708A2 (en) * 2000-11-20 2003-09-03 Scios Inc. Indole-type inhibitors of p38 kinase

Also Published As

Publication number Publication date
US7144914B2 (en) 2006-12-05
HUP0302538A3 (en) 2006-05-29
CN1854138A (zh) 2006-11-01
RU2293085C2 (ru) 2007-02-10
EP1360187A1 (en) 2003-11-12
AR035423A1 (es) 2004-05-26
ATE298339T1 (de) 2005-07-15
ES2243706T3 (es) 2005-12-01
MXPA03006579A (es) 2003-09-22
RU2003121308A (ru) 2005-03-10
HK1063629A1 (en) 2005-01-07
DE60204755T2 (de) 2006-05-18
US20040053986A1 (en) 2004-03-18
HUP0302538A2 (hu) 2003-11-28
PL363454A1 (en) 2004-11-15
UA75382C2 (en) 2006-04-17
KR20030074764A (ko) 2003-09-19
IS6874A (is) 2004-07-11
BR0206791A (pt) 2004-01-27
NO20033434D0 (no) 2003-08-01
JP2004522749A (ja) 2004-07-29
MY136788A (en) 2008-11-28
SE0100326D0 (sv) 2001-02-02
PT1360187E (pt) 2005-10-31
WO2002060902A1 (en) 2002-08-08
CN1489592A (zh) 2004-04-14
SK9702003A3 (en) 2004-01-08
CN1263758C (zh) 2006-07-12
IL156734A0 (en) 2004-02-08
NZ526992A (en) 2005-01-28
EE200300364A (et) 2003-10-15
NO20033434L (no) 2003-09-23
CZ20032061A3 (cs) 2003-10-15
BG108035A (bg) 2003-07-28
ZA200305345B (en) 2004-10-11
EP1360187B1 (en) 2005-06-22
DE60204755D1 (de) 2005-07-28

Similar Documents

Publication Publication Date Title
CA2434970A1 (en) 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias
AU1069101A (en) New oxabispidine compounds useful in the treatment of cardiac arrhythmias
US6559162B2 (en) Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
AU2005254924B2 (en) Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias
US7012074B2 (en) 3,8-Diazabicyclo[3.2.1]octanes and their use in the treatment of cardiac arrhythmias
CA2422810A1 (en) New oxabispidine compound useful in the treatment of cardiac arrhythmias
CA2412848A1 (en) New bispidine compounds and their use in the treatment of cardiac arrhythmias
AU761576B2 (en) New bispidine compounds useful in the treatment of cardiac arrhythmias
AU2002226854A1 (en) 3,7-diazabicyclo[3.30]octanes and their use in the treatment of cardiac arrhythmias
US20030212095A1 (en) New bispidine compounds and their use in the treatment of cardiac arrhythmias
US20040229900A1 (en) Bispidine compounds useful in the treatment of cardiac arrythmias
CA2384339A1 (en) New bispidine compounds useful in the treatment of cardiac arrhythmias

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued